Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02641340 · ClinicalTrials.gov registry record · Phase 1
Fentanyl Sublingual Spray in Opioid Naive Participants
A Phase 1 study, sponsored by INSYS Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 96
- Enrollment target
NCT02641340 is a Phase 1 study that has completed, run by INSYS Therapeutics. The registered enrollment target is 96 participants.
The verdict
NCT02641340, a Phase 1 study, has completed, sponsored by INSYS Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 96 participants
- Enrollment target
Study Summary
The primary objective of this trial is to determine the pharmacokinetic and pharmacodynamic relationship of multiple dose administration of fentanyl sublingual spray in opioid naive participants. The secondary objective is to determine the safety and tolerability of multiple dose administration of fentanyl sublingual spray in opioid naive subjects.
Interventions
- DRUG Fentanyl Sublingual Spray
- DRUG Fentanyl Citrate IV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02641340
The ClinicalTrials.gov registry entry for NCT02641340 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is INSYS Therapeutics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fentanyl Sublingual Spray is the first listed.
NCT02641340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02641340 about?
NCT02641340 is a clinical study titled "Fentanyl Sublingual Spray in Opioid Naive Participants". The primary objective of this trial is to determine the pharmacokinetic and pharmacodynamic relationship of multiple dose administration of fentanyl sublingual spray in opioid naive participants. The secondary objective is to determine the safety and tolerability of multiple dose administration of f...
What is the current status of trial NCT02641340?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 96 participants. The study started on 2016-01. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02641340?
The interventions under investigation include: Fentanyl Sublingual Spray (DRUG), Fentanyl Citrate IV (DRUG).
Who is sponsoring clinical trial NCT02641340?
This trial is sponsored by INSYS Therapeutics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.